Date: 2025/04/29 - 23:00
"Ozempic feet" and "Ozempic mouth" are the latest reported cosmetic side effects from GLP-1 medications used for weight loss. Experts say wrinkles and sagging skin can result from rapid weight loss due to loss of fat and muscle mass in certain areas of the body.
Date: 2025/04/28 - 23:32
Ultra-processed foods (UPFs) are driving rising rates of preventable deaths, a global study reports. For every 10% increase in ultra-processed food consumption, the risk of all-cause mortality rises by 2.7%. UPF intake has been linked to multiple adverse physical and mental health outcomes.
Date: 2025/04/07 - 23:32
Amy Schumer shared she quit Wegovy due to side effects like nausea but was "having a really good experience" with Mounjaro, including improved perimenopause symptoms and sex drive. Side effects with different GLP-1 drugs may vary from person to person.
Date: 2025/04/04 - 12:31
Researchers have developed a blood test based on a protein biomarker for tau tangles that can help diagnose Alzheimer’s disease and also provide insight on how far the disease has progressed.
Date: 2025/04/02 - 23:32
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/02 - 23:00
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/28 - 17:00
Following specific dietary patterns, especially one that scores high on the Alternative Healthy Eating Index, may help a person age healthy with no chronic diseases or cognitive issues at age 70, a new study suggests.
Date: 2025/03/20 - 00:00
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.